Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Equine inhaler receives marketing authorisation
"Treating severe equine asthma can be challenging for veterinarians and horse owners" - Erich Schoett.

Aservo Equihaler® will be available for EU distribution in 2020

A novel equine inhaler set to benefit horses suffering from severe equine asthma has been granted marketing approval by the European Commission.


Marking an industry-first in equine medicine, the Aservo Equihaler® is the culmination of more than a decade of collaboration between Boehringer Ingelheim’s human pharma and animal health R&D groups. It is expected to be available for veterinary surgeons in the EU in 2020.


The inhaler incorporates a unique Soft Mist Technology®, found in the human Respimat® inhaler. This allows the active ingredient - ciclesonide - to be inhaled deep into the lung, thereby reducing the risk of lower airway inflammation.

Designed specifically for horses, the inhaler also features an ergonomic handle, dosing lever for ease of handling and a nostril adaptor that fits inside the nostril of the horse to allow for easy inhalation.

Erich Schoett, global business head of equine for the Boehringer Ingelheim Animal Health Business Unit, said: “Treating severe equine asthma can be challenging for veterinarians and horse owners, who struggle to find safe and effective ways to help horses breathe.


“Bringing a new, safe and effective treatment to the market is something that we can really be proud of. It is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation.”

Become a member or log in to add this story to your CPD history

Vets to run marathon for World Animal Protection

News Story 1
 Two recently graduated veterinary surgeons will be running the London Marathon in April to raise money for the charity World Animal Protection.

Alex Bartlett and Maeve O'Neill plan to run the race together if they are given the same start times.

Dr O'Neill said: "You're always limited in what you can do to help animals, so it is nice to raise money for a charity that helps animals around the world."

Dr Bartlett added: "I have never run a marathon before and am excited to run my first one for such a good cause!"

Both Dr Bartlett and Dr O'Neill have fundraising pages online. 

Click here for more...
News Shorts
BSAVA releases new Guide to Procedures

The British Small Animal Veterinary Association (BSAVA) has published a new edition of its Guide to Procedures for Small Animal Practice.

It has added four new procedures; cystostomy tube placement, endotracheal intubation, point-of-care ultrasound and wet-to-dry dressings.

BSAVA says that it is an essential step-by-step guide to diagnostic and therapeutic procedures performed in practice. The textbook includes new images and illustrations, as well as high-definition videos for use prior to procedures.

Nick Bexfield and Julia Riggs, editors of the new edition, said: "We have built upon the success of the previous editions by responding to the feedback received from the BSAVA readership, and hope this new guide helps to further increase the confidence and accuracy with which these procedures are performed."

Print copies are available in the BSAVA store, with a digital version in the BSAVA library.